4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-035701
Chief Accounting Officer sold 24,000 shares at an average $8.13 ($195,183)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-10 | Sale : show line 1 in the form | −5,989 | $8.00 | $47,925 | 93,910 | D |
| 2022-11-11 | Sale : show line 2 in the form | −18,011 | $8.18 | $147,258 | 75,899 | D |
| Open-market sales · 24,000 sh · avg $8.13 · $195,183 | ||||||
Loading xslF345X03/doc4.xml…